The Asia Pacific surgical robots market is projected to reach USD 4.81 billion by 2031 from USD 2.04 billion in 2025, at a CAGR of 15.4% during the forecast period.
The Asia Pacific surgical robots market continues to expand at a healthy rate, which is primarily attributed to the increasing demand for minimally invasive surgeries (patients as well as hospitals prefer shorter stays, quicker recovery, and fewer complications). China, India, and Southeast Asia are the regions that are progressing most, where healthcare spending and hospital infrastructure investments are increasing. The move of robots from a futuristic concept to the current reality has been facilitated by technological advancements (more affordable and modular robotic platforms, better imaging/AI-assisted guidance, and wider clinical usage [urology, gynecology, orthopedics]). What is more, local manufacturers and a new low-cost entrant are easing the lowering of entry barriers. Demographic and epidemiologic trends (an ageing population and higher chronic-disease/surgical caseloads) combined with the increased number of surgeon training programs, reimbursement enhancements, and strategic partnerships have all together led to hospital purchases and procedure volumes at a higher rate.
To know about the assumptions considered for the study download the pdf brochure
Some of the prominent players operating in the market include Intuitive Surgical (US), Stryker(US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), among other players.
Such companies are pouring substantial amounts of money into research and development to come up with the new generation of robotic platforms that will be used for minimally invasive procedures only. Besides that, the companies are combining advanced imaging, navigation, and AI-enabled capabilities to make the precision higher and the clinical outcomes better in rapidly developing markets like China, Japan, India, South Korea, and Australia. In order to extend their influence in the market, these enterprises are looking for cooperation with leading hospitals, training centers, and distributors. Besides, they are involved in acquisitions and localized manufacturing or assembly, which facilitates system pricing optimization and solving country-specific regulatory and reimbursement issues. Furthermore, the frequent product launches, indications expansion, and regulatory approvals in major Asia Pacific countries contribute to the pace of organic growth by increasing the install base and procedure volumes. At the same time, surgeon training programs and education initiatives help adoption move faster. Hence, these companies maintain their strong competitive position in the region’s surgical robots market, which is expanding rapidly.
In March 2025, MicroPort MedBot proclaimed that its Toumai SP Laparoscopic Surgical Robot had obtained market authorization from the National Medical Products Administration (NMPA) in China. Consequently, the device is permitted to be used in clinical settings across various departments like urology, general surgery, and gynecology.
In January 2025, Prashanth Hospitals, India, inaugurated its Institute of Robotic Surgery alongside a new robotic system to facilitate advanced minimally invasive procedures. These efforts are intended to promote accuracy in the operation, to shorten the time of patient recovery from the wound, and to broaden access to the latest technology of robotic surgery, which is a facility of the hospital network.
In December 2024, the SSI Mantra surgical robot, a Made-in-India system that was recently given the green light by the Central Drugs Standard Control Organisation (CDSCO), found a new home at Noble Hospitals & Research Centre. This event is a significant step locally in the journey of the technology of robotic surgery that is homegrown and India-based in the healthcare sector.
Intuitive Surgical (US)
Intuitive Surgical (US) is at the forefront of the Asia Pacific surgical robots market, using its da Vinci Surgical System to facilitate the widespread use of robotic-assisted minimally invasive surgery in large markets like China, Japan, South Korea, Australia, and India. The company delivers a full line of robotic platforms, instruments, and accessories adaptable to many different fields of medical practice, such as urology, gynecology, general surgery, and thoracic procedures, thus allowing hospitals to carry out complex operations at high levels of precision, control, and visualization. Intuitive’s dominant position in the area is enabled by local training centers, proctoring programs, and digital education initiatives that help surgeons to rapidly acquire skills and to integrate robotic surgery into their everyday clinical practice. The company is still funding innovation and regional growth by upgrading the ergonomics, imaging, and data-driven features of its systems. At the same time, it is deepening collaborations with healthcare providers and governments to facilitate patient access and to increase the da Vinci systems’ market share in the Asia Pacific region.
Stryker (US)
Stryker (US) is one of the major contributors to the Asia Pacific surgical robots market and has an emphasis on the use of orthopedics through its Mako SmartRobotics platform. The company is actively involved in the expansion of Mako systems installation in the hospital network of the top district hospitals in countries like Australia, Japan, South Korea, India, and China, where the technology, being used mainly in knee and hip arthroplasty, is slowly but steadily spreading into additional joint indications. The Mako system incorporates CT-based preoperative planning, a robotic arm, and real-time haptic feedback, thus enabling surgeons to perform bone preparation and implant placement that is anatomically precise, thereby supporting better functional outcomes and shorter recovery times for patients in the region. Stryker’s plan in the Asia Pacific is to connect its implant portfolio with the Mako platform while also spending on surgeon education, clinical evidence generation, and creating relationships with the centers of high-volume, thus making orthopedic workflows more efficient and strengthening its position as a competitor in the surgical robotics market of the region.
Market Ranking
The Asia Pacific surgical robots market is consolidated and primarily dominated by Intuitive Surgical. This is because of the largest installed base of da Vinci systems, high procedure volumes, and deep integration into hospital workflows in the major countries. One of the leading players in orthopedic robotics is Stryker, and its Mako platform is the most attractive for knee and hip replacement surgery in European joint-replacement centers. With the Hugo RAS system and its numerous hospital relationships, Medtronic is a very aggressive challenger who is going to new tender wins and footprint expansions. Zimmer Biomet is focusing next on ROSA Knee and ROSA Spine, which are, thus, becoming widely accepted in the orthopedic and spine surgery departments. ROSA- Knee and ROSA-Spine are the products of Zimmer Biomet, which is the next company, slowly gaining adoption in the orthopedic and spine surgery units. At present, Smith+Nephew has limited expansion potential with the CORI system, but is shaping itself as a future competitor in digital and orthopedic robotic surgery in Asia Pacific.
Related Reports:
Asia Pacific Surgical Robots Market by Offering (Instruments & Accessories, Robotic Systems [Laparoscopy, Orthopedic], Services), Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Specialty Clinics, ASCs) - Forecast to 2031
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
